Precision BioSciences Inc (DTIL) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.99
• Market Cap: $98.69M
• EPS: $-8.96
• 52-Week High: $8.82
• 52-Week Low: $3.53

Market Sentiment

Precision BioSciences Inc currently has a Bearish sentiment score of -0.36.

About Precision BioSciences Inc

Precision BioSciences, Inc. (Ticker: DTIL) is a pioneering genome editing company based in Durham, North Carolina, renowned for its innovative therapeutic products aimed at treating a diverse array of diseases. Utilizing its proprietary ARCUS platform, the company excels in developing highly precise genetic therapies, with a strategic focus on oncology, genetic disorders, and infectious diseases. With a promising pipeline and a firm commitment to advancing genetic medicine, Precision BioScien...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Precision BioSciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does DTIL pay dividends?

Precision BioSciences Inc (DTIL) does not currently pay a regular dividend.

What is DTIL's market cap?

Precision BioSciences Inc (DTIL) has a market capitalization of $98.69M with a current stock price of $3.99.